Eric Beltrami

Dr. Eric Beltrami


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2025 in Dermatopathology
Verified
Journal Article
Open access
PDF file
AZAurore Zhang
Aurore Zhang
MLMichelle Lazar
Michelle Lazar
EAEmiliya Akhundova
Emiliya Akhundova
CBCandice E. Brem
Candice E. Brem
EBEric Beltrami
Eric Beltrami
Neelam A. VashiNeelam A. Vashi
Neelam A. Vashi
Melasma is an incredibly common dyschromic disorder, mostly impacting women with skin of color. There are three variants of melasma based on the depth of pathologic involvement: epidermal, mixed, and dermal. While there are many treatments for melasma, there is a paucity of research on melasma treatments and their dermatopathological correlates. A scoping review was conducted of all human trials on melasma with histopathologic analysis, including 37 trials in the final analysis. Most studies were conducted on women with a Fitzpatrick skin type of III or greater. Strong histologic evidence supports the utilization of retinols/retinoids for epidermal melasma and microneedling for dermal melasma. There is a paucity of trials conducted on melasma utilizing histologic correlates, and fewer still that are comprehensive to include analyses on quality of life.